David Drutz - 15 Aug 2023 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
Issuer symbol
ALT
Transactions as of
15 Aug 2023
Net transactions value
+$862
Form type
4
Filing time
15 Aug 2023, 18:46:57 UTC
Previous filing
27 Mar 2023
Next filing
29 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Purchase $862 +300 +1% $2.88 29,785 15 Aug 2023 See Footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock purchased and immediately transferred to Pacific Biopharma Associates, LLC.
F2 Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.